Literature DB >> 21533729

Oral contraceptives in migraine therapy.

Gianni Allais1, Ilaria Castagnoli Gabellari, Cristina De Lorenzo, Ornella Mana, Chiara Benedetto.   

Abstract

Even if sometimes combined oral contraceptives (COCs) can initiate or aggravate headaches, in particular migraine, the headaches generally tend to improve after the first months of COC use. If migraine persists, in many patients the attacks are more likely to occur during the pill-free week, and an oral contraceptive-induced menstrual migraine (OCMM) occurs. In case of OCMM, some hormonal manipulations are available, by eliminating or reducing the hormone-free interval (HFI), in order to prevent this estrogen-withdrawal headache. It is possible to use a continuous COCs regimen, to shorten the HFI to less than the traditional 7 days, to use a low-dose estrogen supplementation after the 21 days of COCs or to prescribe a progestogen-only pill (POP). Interestingly, the use of a POP is a safe option also for women suffering from migraine with aura (in which COCs are absolutely contraindicated) and a recent trial suggests that its use can reduce the frequency of migraine attacks and the duration of aura symptoms too.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533729     DOI: 10.1007/s10072-011-0538-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

1.  A comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily.

Authors:  C F Rice; S R Killick; T Dieben; H Coelingh Bennink
Journal:  Hum Reprod       Date:  1999-04       Impact factor: 6.918

2.  Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms.

Authors:  Patricia J Sulak; Thomas J Kuehl; Mirian Ortiz; Bobby L Shull
Journal:  Am J Obstet Gynecol       Date:  2002-06       Impact factor: 8.661

Review 3.  Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review.

Authors:  Elizabeth W Loder; Dawn C Buse; Joan R Golub
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

4.  ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions.

Authors: 
Journal:  Obstet Gynecol       Date:  2006-06       Impact factor: 7.661

Review 5.  The influence of estrogen on migraine: a systematic review.

Authors:  Jan Lewis Brandes
Journal:  JAMA       Date:  2006-04-19       Impact factor: 56.272

6.  Effects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: a prospective diary-based pilot study.

Authors:  Rossella E Nappi; Grazia Sances; Gianni Allais; Erica Terreno; Chiara Benedetto; Valentina Vaccaro; Franco Polatti; Fabio Facchinetti
Journal:  Contraception       Date:  2010-09-20       Impact factor: 3.375

7.  Predictability of exogenous hormone effect on subgroups of migraineurs.

Authors:  L Mueller
Journal:  Headache       Date:  2000-03       Impact factor: 5.887

8.  Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura.

Authors:  L M Cupini; M Matteis; E Troisi; P Calabresi; G Bernardi; M Silvestrini
Journal:  Cephalalgia       Date:  1995-04       Impact factor: 6.292

9.  Oral contraceptive-induced menstrual migraine. Clinical aspects and response to frovatriptan.

Authors:  Gianni Allais; Gennaro Bussone; Gisella Airola; Paola Borgogno; Ilaria Castagnoli Gabellari; Cristina De Lorenzo; Elena Pavia; Chiara Benedetto
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

10.  Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.

Authors:  F Granella; G Sances; C Zanferrari; A Costa; E Martignoni; G C Manzoni
Journal:  Headache       Date:  1993 Jul-Aug       Impact factor: 5.887

View more
  2 in total

1.  The risk of breast cancer associated with specific patterns of migraine history.

Authors:  Sarah J Lowry; Kathleen E Malone; Kara L Cushing-Haugen; Christopher I Li
Journal:  Cancer Causes Control       Date:  2014-10-31       Impact factor: 2.506

Review 2.  Migraine and breast cancer risk: a meta-analysis of observational studies based on MOOSE compliant.

Authors:  Xiujuan Wu; Minghao Wang; Shifei Li; Yi Zhang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.